Ignite Creation Date:
2024-05-05 @ 11:53 AM
Last Modification Date:
2024-10-26 @ 9:16 AM
Study NCT ID:
NCT00168948
Status:
UNKNOWN
Last Update Posted:
2005-11-02
First Post:
2005-09-13
Brief Title:
Intermittent Antimalaria Treatment With SP in African Children
Sponsor:
Charite University Berlin Germany
Organization:
Charite University Berlin Germany
Study Overview
Official Title:
Intermittent Treatment With Sulfadoxine-Pyrimethamine for Malaria Control in Children A Randomised Double Blind and Placebo-Controlled Clinical Trial
Status:
UNKNOWN
Status Verified Date:
2003-02
Last Known Status:
ACTIVE_NOT_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
- intermittent preventive treatment with SP in children to evaluate efficacy and safety of this drug combination in children in northern Ghana
Detailed Description:
Sulfadoxine and pyrimethamine have long been used for malaria prevention and treatment In this study following suggestions of WHO these drugs are used for intermittent treatment
It will be tested if this approach reduces the number of malaria attacks and ameliorates the severity of the disease
It will also be determined if anemia due to malaria which is prevalent in northern Ghana may be reduced
Moreover the interaction between red cell polymorphisms such as HbS HbC alpha-thalassemia and glucose-6-phosphate dehydrogenase deficiency and SP will be examined
It will be tested if this approach reduces the number of malaria attacks and ameliorates the severity of the disease
It will also be determined if anemia due to malaria which is prevalent in northern Ghana may be reduced
Moreover the interaction between red cell polymorphisms such as HbS HbC alpha-thalassemia and glucose-6-phosphate dehydrogenase deficiency and SP will be examined
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 01KA0202 | None | None | None |